IL108786A0 - 4-aminopyridines, processes for their production and pharmaceutical agents containing them - Google Patents

4-aminopyridines, processes for their production and pharmaceutical agents containing them

Info

Publication number
IL108786A0
IL108786A0 IL10878694A IL10878694A IL108786A0 IL 108786 A0 IL108786 A0 IL 108786A0 IL 10878694 A IL10878694 A IL 10878694A IL 10878694 A IL10878694 A IL 10878694A IL 108786 A0 IL108786 A0 IL 108786A0
Authority
IL
Israel
Prior art keywords
stands
atom
compounds
hydrogen
halogen
Prior art date
Application number
IL10878694A
Other versions
IL108786A (en
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4306506A external-priority patent/DE4306506A1/en
Priority claimed from DE19934312966 external-priority patent/DE4312966A1/en
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of IL108786A0 publication Critical patent/IL108786A0/en
Publication of IL108786A publication Critical patent/IL108786A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

New 4-aminopyridines have general formula (I), in which R<1> stands for the groups R<6>-SO-NR<7>, R<6>-SO2-NR<7>, R<6>-NR<7>-SO-, R<6>-NR<7>-SO2-, R<6>-SO-O-, R<6>-SO2-O-, R<6>-O-SO- or R<6>-O-SO2; R<2> stands for a hydrogen or halogen atom, a cyano, alkyl, alkoxy or halogen alkyl group; X stands for an oxygen atom, a sulphur atom or the NH group; R<3> and R<4> are the same or different and stand for hydrogen atoms or alkyl groups; R<5> stands for a hydrogen atom, an alkyl group or the aralkyl group; R<6> stands for an aliphatic or cyclic, if required substituted residue; R<7> stands for a hydrogen atom or an aliphatic or cyclic, if required substituted residue; Y stands for a linear or branched alkylene chain; R<8> and R<9> are the same or different and stand for hydrogen atoms, aralkyl, cycloalkyl or alkyl groups which may be substituted once or several times by halogen, hydroxy, alkoxy, alkylcarbonyloxy, amine or carboxy, or R<8> and R<9> form together with the N atom to which they are bound a saturated ring which may contain an additional oxygen, sulphur or nitrogen atom. Also disclosed are the hydrates, solvates and physiologically acceptable salts of these compounds, their optically active forms, racemates and diastereomer mixtures, a process for preparing said compounds, medicaments containing said compounds and the use of said compounds for producing medicaments.
IL10878694A 1993-03-03 1994-02-28 4-aminopyridines processes for their production and pharmaceutical compositions containing them IL108786A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4306506A DE4306506A1 (en) 1993-03-03 1993-03-03 Novel 4-alkylaminopyridines - processes for their preparation and medicaments containing these compounds
DE19934312966 DE4312966A1 (en) 1993-04-21 1993-04-21 Novel 4-aminopyridines - process for their preparation and medicaments containing these compounds

Publications (2)

Publication Number Publication Date
IL108786A0 true IL108786A0 (en) 1994-06-24
IL108786A IL108786A (en) 1999-04-11

Family

ID=25923593

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10878694A IL108786A (en) 1993-03-03 1994-02-28 4-aminopyridines processes for their production and pharmaceutical compositions containing them

Country Status (22)

Country Link
EP (1) EP0687253B1 (en)
JP (1) JPH08507503A (en)
KR (1) KR100252551B1 (en)
CN (1) CN1046710C (en)
AT (1) ATE174590T1 (en)
AU (1) AU682026B2 (en)
CA (1) CA2156729A1 (en)
CZ (1) CZ225495A3 (en)
DE (1) DE59407494D1 (en)
DK (1) DK0687253T3 (en)
ES (1) ES2127919T3 (en)
FI (1) FI954105A (en)
GR (1) GR3029691T3 (en)
HU (1) HUT72898A (en)
IL (1) IL108786A (en)
NO (1) NO953447L (en)
NZ (1) NZ262725A (en)
PL (1) PL176455B1 (en)
RU (1) RU2126388C1 (en)
SK (1) SK108295A3 (en)
TW (1) TW257757B (en)
WO (1) WO1994020467A1 (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4430755A1 (en) * 1994-08-30 1996-03-07 Boehringer Mannheim Gmbh New phosphine oxides, processes for their preparation and medicaments containing these compounds
IL115420A0 (en) 1994-09-26 1995-12-31 Zeneca Ltd Aminoheterocyclic derivatives
US5792769A (en) * 1995-09-29 1998-08-11 3-Dimensional Pharmaceuticals, Inc. Guanidino protease inhibitors
GB9525620D0 (en) 1995-12-15 1996-02-14 Glaxo Group Ltd Chemical compounds
BR9612360A (en) 1995-12-29 1999-07-13 Dimensional Pharm Inc Amidino protease inhibitors
GB9602166D0 (en) 1996-02-02 1996-04-03 Zeneca Ltd Aminoheterocyclic derivatives
AU1608397A (en) 1996-02-02 1997-08-22 Zeneca Limited Heterocyclic compounds useful as pharmaceutical agents
SE9602646D0 (en) 1996-07-04 1996-07-04 Astra Ab Pharmaceutically useful compounds
CA2260872A1 (en) * 1996-08-14 1998-02-19 Elaine Sophie Elizabeth Stokes Substituted pyrimidine derivatives and their pharmaceutical use
JP2001500864A (en) * 1996-09-13 2001-01-23 メルク エンド カンパニー インコーポレーテッド Thrombin inhibitors
GB9821483D0 (en) 1998-10-03 1998-11-25 Glaxo Group Ltd Chemical compounds
UA56197C2 (en) 1996-11-08 2003-05-15 Зенека Лімітед Heterocyclic derivatives
TW499412B (en) 1996-11-26 2002-08-21 Dimensional Pharm Inc Aminoguanidines and alkoxyguanidines as protease inhibitors
WO1998024760A1 (en) * 1996-12-03 1998-06-11 Graybill Todd L Aminobenzenedicarboxylic acid-based combinatorial libraries
DE69815509T2 (en) 1997-02-13 2004-05-13 Astrazeneca Ab HETEROCYCLIC COMPOUNDS THAT APPLY AS OXIDO-SQUALEN-CYCLASE INHIBITORS
US6440972B1 (en) 1997-02-13 2002-08-27 Zeneca Limited Heterocyclic compounds useful as oxido-squalene cyclase inhibitors
GB9715895D0 (en) 1997-07-29 1997-10-01 Zeneca Ltd Heterocyclic compounds
JP4327915B2 (en) * 1998-03-30 2009-09-09 株式会社デ・ウエスタン・セラピテクス研究所 Sulfonamide derivatives
AU754253B2 (en) 1998-10-06 2002-11-07 Dainippon Pharmaceutical Co. Ltd. 2,3-disubstituted pyridine derivatives, processes for the preparation thereof, pharmaceutical compositions containing the same and intermediates therefor
GB9902989D0 (en) 1999-02-11 1999-03-31 Zeneca Ltd Heterocyclic derivatives
AR023510A1 (en) 1999-04-21 2002-09-04 Astrazeneca Ab A TEAM OF PARTS, PHARMACEUTICAL FORMULATION AND USE OF A THROMBIN INHIBITOR.
EP1307432A1 (en) 2000-08-04 2003-05-07 3-Dimensional Pharmaceuticals, Inc. Cyclic oxyguanidine protease inhibitors
WO2002089740A2 (en) * 2001-05-07 2002-11-14 Smithkline Beecham Corporation Sulfonamides
US6849635B2 (en) * 2001-05-07 2005-02-01 Smithkline Beecham Corporation Sulfonamides
US7476683B2 (en) 2002-08-27 2009-01-13 Merck Patent Gmbh Glycinamide derivatives as raf-kinase inhibitors
BR0314126A (en) 2002-09-20 2005-06-28 Pfizer Prod Inc Acyclic Amide and Sulphonamide Ligands for Estrogen Receptor
RU2374230C2 (en) 2003-11-05 2009-11-27 Ф.Хоффманн-Ля Рош Аг Phenyl derivatives as ppar agonists
WO2008104994A2 (en) * 2007-02-28 2008-09-04 Advinus Therapeutics Private Limited 2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application
RU2354647C2 (en) * 2007-06-28 2009-05-10 Общество С Ограниченной Ответственностью "Бионика" New compounds with thrombin inhibiting function, and based pharmaceutical compositions
RU2353619C2 (en) * 2007-06-28 2009-04-27 Общество С Ограниченной Ответственностью "Бионика" Novel compounds possessing anticoagulant function, based on them pharmaceutical compositions for treatment of thrombotic conditions and plasma-substituting solution for correction of hypercoagulation disorders in hemodilution
GB0815784D0 (en) * 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
GB0815781D0 (en) 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
GB0815782D0 (en) 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
US8265575B2 (en) * 2009-06-16 2012-09-11 Mediatek Inc. Methods for handling a transmitting process and communication apparatuses utilizing the same
US8207639B2 (en) 2009-10-23 2012-06-26 Sunonwealth Electric Machine Industry Co., Ltd. Motor and heating dissipating fan including motor having an annular balancing member
RU2685261C1 (en) * 2018-04-05 2019-04-17 Общество с ограниченной ответственностью "ФК ЛАБОРАТОРИЗ" 4-amino-1-{2-[3-methyl-5-(benzenesulfonyloxy]phenoxy]ethyl}-pyridium chloride substance, having the biologically active agent properties, influencing the mammals blood coagulability naturally running processes, anticoagulant on its basis and its obtaining method by chemical synthesis
CN109172573B (en) * 2018-09-12 2021-01-26 黑龙江中桂制药有限公司 Oral antithrombotic drug and application thereof
CN110669337B (en) * 2019-07-08 2020-09-25 中国科学院长春应用化学研究所 Aromatic diamine monomer and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8819307D0 (en) * 1988-08-13 1988-09-14 Pfizer Ltd Antiarrhythmic agents
JPH0256465A (en) * 1988-08-22 1990-02-26 Hamari Yakuhin Kogyo Kk Acetamide compound
JPH07501057A (en) * 1991-10-31 1995-02-02 スミスクライン・ビーチャム・コーポレイション C8-cyclic peptide mimetics for fibrinogen antagonists
WO1993010091A2 (en) * 1991-11-14 1993-05-27 Glaxo Group Limited Piperidine acetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation
DE4212304A1 (en) * 1992-04-13 1993-10-14 Cassella Ag Aspartic acid derivatives, their preparation and use

Also Published As

Publication number Publication date
GR3029691T3 (en) 1999-06-30
KR100252551B1 (en) 2000-05-01
DE59407494D1 (en) 1999-01-28
DK0687253T3 (en) 1999-08-23
EP0687253B1 (en) 1998-12-16
FI954105A0 (en) 1995-09-01
HU9502568D0 (en) 1995-11-28
TW257757B (en) 1995-09-21
EP0687253A1 (en) 1995-12-20
NZ262725A (en) 1997-05-26
NO953447D0 (en) 1995-09-01
CN1119858A (en) 1996-04-03
IL108786A (en) 1999-04-11
HUT72898A (en) 1996-06-28
ES2127919T3 (en) 1999-05-01
AU6257494A (en) 1994-09-26
CA2156729A1 (en) 1994-09-15
CZ225495A3 (en) 1996-01-17
WO1994020467A1 (en) 1994-09-15
FI954105A (en) 1995-09-01
RU2126388C1 (en) 1999-02-20
AU682026B2 (en) 1997-09-18
SK108295A3 (en) 1996-06-05
CN1046710C (en) 1999-11-24
NO953447L (en) 1995-09-01
PL310520A1 (en) 1995-12-27
PL176455B1 (en) 1999-05-31
KR960701019A (en) 1996-02-24
JPH08507503A (en) 1996-08-13
ATE174590T1 (en) 1999-01-15

Similar Documents

Publication Publication Date Title
IL108786A0 (en) 4-aminopyridines, processes for their production and pharmaceutical agents containing them
ZA919181B (en) Oxazolopyridine derivatives,processes for preparing these and pharmaceutical compositions containing them
PL317604A1 (en) Derivatives of amides, method of obtaining them and pharmaceutic compositions containing such derivatives
ZA932168B (en) Naphthylalkylamines, process for preparing them and pharmaceutical compositions containing them
DE68900180D1 (en) AMINE, THEIR USE AND PRODUCTION.
ZA924966B (en) Vanadium complexes,process for preparing them and pharmaceutical compositions containing them
HU9401943D0 (en) Process for producing amide and urea derivatives and compositions containing them
MX9707053A (en) Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds.
IL102093A0 (en) 1-methylcarbapenem derivatives,processes for the preparation thereof,and pharmaceutical compositions containing the same
HU9802143D0 (en) New heterocyclic compounds of 5 members in the ring, process for producing them and pharmaceutical compositions containing them
SG47947A1 (en) Biologically active amines
YU5896A (en) Use of amides phenylcyclohexylcarbonic acid, single amides of phenylcyclohexylcarbonic acid, process for their production and medicaments containing them
ZA912618B (en) 3-aminochroman derivatives,process for preparing these and pharmaceutical compositions containing them
ATE116647T1 (en) THIOPHENE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
PL326554A1 (en) Derivatives of amine and thiourea and inhibitors of nitrogen oxide synthase
TW259785B (en) Chemical compounds
UA50722C2 (en) Nitrobenzamides, method for their production (variants), pharmaceutical composition
ZA918991B (en) Imidazole compounds,process for the preparation thereof and pharmaceutical compositions containing them
ATE231136T1 (en) THIAZOLIDINEDIONE DERIVATIVES HAVING ANTIDIABETIC, HYPOLIPIDEMIC AND ANTIHYPERTENSIVE PROPERTIES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DE68905363T2 (en) HETEROTETRACYCLIC LACTAM DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS THEREOF.
ATE168371T1 (en) 5-AMINO-5,6,7,8-TETRAHYDROCINOLINES AND RELATED COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICINAL PRODUCTS
HUT58273A (en) Process for producing aminoketon compounds and pharmaceutical compositions containing them
ZA881384B (en) Acetamides derived from 2,3-dihydro-3-phenyl-2-benzofuranone,processes for preparing them and the pharmaceutical compositions which contain them
ZA909557B (en) Substituted benzothiazolinones,process for preparing these and pharmaceutical compositions containing them
MY105843A (en) Glycerol derivatives, a preparation process of the same and therapeutical compositions containing them.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
RH1 Patent not in force